CONMED (CNMD) Earnings Analysis

CONMED (CNMD) next reports earnings on 2026-07-29, consensus EPS 1.1 USD. Last quarter (2026-04-29) it beat with EPS 0.89 USD vs 0.82 USD est (+8.5%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E 23.70.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does CNMD next report earnings?

Next earnings date2026-07-29
Consensus EPS estimate1.1 USD
Revenue estimate0.34B

CNMD earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-290.89 USD0.82 USD+8.5%Beat
2026-01-281.43 USD1.32 USD+8.3%Beat
2025-07-301.15 USD1.13 USD+1.8%Beat
2025-04-300.95 USD0.81 USD+17.3%Beat
2025-02-051.34 USD1.2 USD+11.7%Beat

Beat rate: 5/5 (100%) over reported quarters with consensus data.

CNMD valuation and analyst view

Trailing P/E23.70
Trailing EPS1.793 USD
Price / book1.26
Dividend yield0.48%
Market cap1.26B
Analyst consensusHold (7 buy / 13 hold / 1 sell)
Avg price target37.5 USD

Related research pages

Frequently asked questions

When is CONMED (CNMD)'s next earnings date?

CONMED is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 1.1 USD and revenue estimate of 0.34B.

Did CNMD beat earnings last quarter?

In its 2026-04-29 report, CNMD posted EPS of 0.89 USD versus a 0.82 USD estimate — a beat of 8.5%.

What is CNMD's earnings track record?

Over the last 5 reported quarters with consensus data, CNMD beat estimates 5 times (100%).

What is CNMD's current P/E ratio and EPS?

CNMD trades at a trailing P/E of 23.70 on trailing EPS of 1.7930887929907153 USD.

What do analysts rate CNMD?

Analyst consensus is "Hold" across 21 ratings (0 strong buy, 7 buy, 13 hold, 1 sell, 0 strong sell). Average 12-month price target: 37.5 USD.